Therapeutic Asset Ratings
130 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
TSC-101
Myelodysplastic Syndrome
TScan Therapeutics, Inc.
P1
C
(37)
Vactosertib
Myelodysplastic Syndrome
David Wald
P1
C
(37)
Sabatolimab
Myelodysplastic Syndrome
Novartis Pharmaceuticals
P1/2
C
(37)
Erythropoietin Human Recombinant
Myelodysplastic Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
D
(28)
Fecal Microbiome
Myelodysplastic Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
D
(28)
Showing 126 to 130 of 130 assets
Previous
Page 6 of 6
Next
